AR048274A1 - Sintesis estereoselectiva de analogos de vitamina d - Google Patents

Sintesis estereoselectiva de analogos de vitamina d

Info

Publication number
AR048274A1
AR048274A1 ARP050101046A ARP050101046A AR048274A1 AR 048274 A1 AR048274 A1 AR 048274A1 AR P050101046 A ARP050101046 A AR P050101046A AR P050101046 A ARP050101046 A AR P050101046A AR 048274 A1 AR048274 A1 AR 048274A1
Authority
AR
Argentina
Prior art keywords
general structure
enriched
mixture
compounds
defined above
Prior art date
Application number
ARP050101046A
Other languages
English (en)
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of AR048274A1 publication Critical patent/AR048274A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 2: Un método para producir calcipotriol o monohidrato de calcipotriol que comprende los pasos de (a)-(b) de la reivindicacion 1 y adicionalmente que comprende los pasos de: (f) isomerizar la mezcla de compuestos de estructura general Va y Vb, en donde R1 y R2 son segun lo definido anteriormente, la cual es enriquecida con Va, hasta una mezcla de compuestos de la estructura general VIa y VIb, la cual es enriquecida con VIa, en donde R1 y R2 son segun lo definido anteriormente; (g) separar opcionalmente el compuesto de estructura general VIa de la mezcla de compuestos de estructura general VIa y VIb la cual es enriquecida con VIa, en donde R1 y R2 son segun lo definido anteriormente; (h) cuando R1 y/o R2 no son H, eliminar el o los grupos protectores de hidroxi R1 y/o R2 del compuesto de estructura general VIa para generar calcipotriol. Reivindicacion 23: Un método de acuerdo con las reivindicaciones 1-22, en donde R1 y R2 representan alquilsililo.
ARP050101046A 2004-03-18 2005-03-17 Sintesis estereoselectiva de analogos de vitamina d AR048274A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55396204P 2004-03-18 2004-03-18
DKPA200400454 2004-03-22

Publications (1)

Publication Number Publication Date
AR048274A1 true AR048274A1 (es) 2006-04-12

Family

ID=34961016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101046A AR048274A1 (es) 2004-03-18 2005-03-17 Sintesis estereoselectiva de analogos de vitamina d

Country Status (17)

Country Link
EP (1) EP1730108B1 (es)
JP (1) JP4667450B2 (es)
KR (1) KR100859277B1 (es)
CN (1) CN1934078B (es)
AR (1) AR048274A1 (es)
AT (1) ATE390411T1 (es)
BR (1) BRPI0507318A (es)
CA (1) CA2555260C (es)
CY (1) CY1108156T1 (es)
DE (2) DE05706821T1 (es)
ES (1) ES2304686T3 (es)
IL (1) IL176718A (es)
PL (1) PL1730108T3 (es)
RU (1) RU2380359C2 (es)
SI (1) SI1730108T1 (es)
TW (1) TWI324063B (es)
WO (1) WO2005087719A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070056001A (ko) * 2004-04-02 2007-05-31 레오 파마 에이/에스 비타민 d 동족체의 합성에 유용한 중간체의 신규한제조방법
ES2406735T3 (es) 2006-03-17 2013-06-07 Leo Pharma A/S Isomerización de compuestos intermedios farmacéuticos
US8013189B2 (en) * 2007-09-21 2011-09-06 Basf Se Accelerated amide and ester reductions with amine boranes and additives
EP2299809B1 (en) * 2008-06-17 2018-10-17 Ben Gurion University Of The Negev R&D Authority Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
CN103265528B (zh) * 2013-05-10 2015-05-06 湖南千金湘江药业股份有限公司 埃索美拉唑镁的制备方法
CN106908524B (zh) * 2015-12-23 2021-05-04 重庆华邦胜凯制药有限公司 卡泊三醇中间体l及其潜在基因毒性杂质的分离与测定方法
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
ES2945426B2 (es) * 2021-12-30 2024-01-22 Laboratorios Vinas S A Procedimiento para obtener epímeros 24S a partir de derivados de vitaminas D y procedimiento de obtención de vitaminas D relacionado

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3666587D1 (en) * 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
JPH075542B2 (ja) * 1988-09-14 1995-01-25 呉羽化学工業株式会社 ビタミンd▲下3▼誘導体及びその製造方法
US5247104A (en) * 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
WO2000024712A1 (en) * 1998-10-23 2000-05-04 Teijin Limited Vitamin d3 derivatives and remedies for inflammatory respiratory diseases containing the same

Also Published As

Publication number Publication date
KR100859277B1 (ko) 2008-09-19
IL176718A (en) 2007-07-04
HK1098122A1 (en) 2007-07-13
ES2304686T3 (es) 2008-10-16
RU2380359C2 (ru) 2010-01-27
WO2005087719A1 (en) 2005-09-22
ATE390411T1 (de) 2008-04-15
BRPI0507318A (pt) 2007-06-26
CA2555260C (en) 2011-12-06
TW200539866A (en) 2005-12-16
CY1108156T1 (el) 2014-02-12
SI1730108T1 (sl) 2008-08-31
CN1934078B (zh) 2011-07-06
TWI324063B (en) 2010-05-01
EP1730108B1 (en) 2008-03-26
JP4667450B2 (ja) 2011-04-13
DE05706821T1 (de) 2008-02-07
KR20060134045A (ko) 2006-12-27
JP2007529433A (ja) 2007-10-25
CA2555260A1 (en) 2005-09-22
DE602005005645D1 (de) 2008-05-08
DE602005005645T2 (de) 2009-06-18
CN1934078A (zh) 2007-03-21
EP1730108A1 (en) 2006-12-13
RU2006129922A (ru) 2008-02-27
PL1730108T3 (pl) 2008-09-30

Similar Documents

Publication Publication Date Title
ECSP066858A (es) Inhibidores de gsk-3
NI200500090A (es) Compuestos de benzofurano, composiciones y metodos para tratamiento y profilafixis de infecciones virales de hepatitis c y enfermedades asociadas
UA87115C2 (ru) Ацетоновый сольват диметоксидоцетаксела и способ его получения
AR067316A1 (es) Moleculas secuestradoras de oxigeno, articulos que las contienen y metodos para su uso
CO5550420A2 (es) Proceso para la preparacion de citalopram racemico y/o del s- o r- citalopram mediante la separacion de la mezcla de r- y s- citalopram
PE20220169A1 (es) Compuestos macrociclicos como agonistas de sting
AR109669A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano
AR069225A1 (es) Procedimiento de preparacion de compuestos morfinicos
MY146099A (en) Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
CY1108156T1 (el) Στερεοεκλεκτικη συνθεση αναλογων βιταμινης d
ATE374760T1 (de) Verfahren zur herstellung von 4-fluor-1,3- dioxolan-2-on
AR044296A1 (es) Metodo para la racemizacion de la (s) - (+) y de la (r) - (-) -10, 11-dihidro-10-hidroxi-5h-dibenz [b,f] azepin-5- carboxamida, y mezclas opticamente enriquecidas de las mismas
GT200500311A (es) Compuestos organicos
EP1623982A4 (en) METHOD FOR PRODUCING DOCETAXEL TRIHYDRATE
ES2531393T3 (es) Proceso de semisíntesis para la preparación de 10 desacetil-N-desbenzoil-paclitaxel
MY148301A (en) Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
MX2024014229A (es) Metodos de flujo continuo para producir manosa-1-fosfato, polimorfos de manosa-1-fosfato y composiciones y usos relacionados con los mismos
TW200619187A (en) Epimerisation of allylic alcohols
UY29069A1 (es) Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia
AR058284A1 (es) Proceso ajustable a escala para la preparacion de un 42- ester de rapamicina a partir de un boronato de 42- ester de rapamicina
AR111318A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano
WO2007038250A3 (en) 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof
AR083541A1 (es) Derivado de 23-ino-vitamina d
AR117958A1 (es) Síntesis del (s)-6-hidroxitriptófano y derivados del mismo
AR001561A1 (es) Procedimiento para la obtención de cis isómeros sustancialmente puros a partir de una mezcla de isómeros cis y trans de o-bisoximas

Legal Events

Date Code Title Description
FB Suspension of granting procedure